TABLE 1 Characteristics of Patients with Clinical Splenomegaly

From: The AIDS Autopsy Spleen: A Comparison of the Pre-Anti-Retroviral and Highly Active Anti-Retroviral Therapy Eras

Pt. No.

Year

Age (y)

Cohort

Weight (g)

Clinical Diagnosis

Spleen Involvement

Treatment

1

1982

34

pre-HAART

510

CMV

no

N/A

2

1989

40

pre-HAART

650

MAI, CMV, PCP

CMV, PCP

N/A

3

1990

52

pre-HAART

280

PCP

no

AZT

4

1992

41

pre-HAART

370

CMV, PCP

no

AZT

5

1992

46

pre-HAART

1290

large cell lymphoma

yes

N/A

6

1993

48

pre-HAART

140

CMV, PCP

PCP

N/A

7

1993

34

pre-HAART

750

MAI

No

AZT

8

1994

42

pre-HAART

700

CMV, MAI, KS

MAI, KS

MA

9

1996

35

HAART

720

large cell lymphoma

Yes

MA

10

1997

40

HAART

610

CMV, MAI

CMV, MAI

no

  1. CMV, cytomegalovirus; MAI, mycobacterium avium intracellulare; PCP, pneumocystis carinii pneumonia; Ly, lymphoma; MA, multiagent therapy; KS, Kaposi's sarcoma; HAART, highly active antiretroviral therapy; N/A, not available; AZT, azidothymidine